VCM
MYGN icon

Voleon Capital Management’s Myriad Genetics MYGN Stock Holding History

Voleon Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.21M Buy
211,757
+74,516
+54% +$338K 0.02% 444
2026
Q1 		$618K Buy
137,241
+68,436
+99% +$357K 0.01% 532
2025
Q4 		$423K Sell
68,805
-45,721
-40% -$332K 0.01% 611
2025
Q3 		$828K Buy
114,526
+45,898
+67% +$273K 0.02% 473
2025
Q2 		$364K Buy
+68,628
New +$405K 0.02% 372

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Voleon Capital Management's MYGN Position: Q2 2026 in Review

Voleon Capital Management increased its Myriad Genetics (MYGN) stake by 54% in Q2 2026, buying an estimated $338K and bringing the position to 211,757 shares worth $1.21M. The position accounts for 0.02% of the portfolio, ranked #444.

Voleon Capital Management first reported a position in MYGN in Q2 2025 and has held it in 5 quarters since. 197 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.

  • Voleon Capital Management held 211,757 shares of Myriad Genetics worth $1.21M as of Q2 2026.
  • Voleon Capital Management bought 74,516 Myriad Genetics shares in Q2 2026, an estimated $338K.
  • Myriad Genetics made up 0.02% of Voleon Capital Management's portfolio in Q2 2026, its #444 holding.
  • Voleon Capital Management first reported a position in Myriad Genetics in Q2 2025 and has held it in 5 quarters since.
  • 197 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.